195 related articles for article (PubMed ID: 3505841)
1. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
Godley PJ; Black JT; Frohna PA; Garrelts JC
Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the vancomycin-clearance:creatinine-clearance relationship for predicting vancomycin dosage.
Matzke GR; Kovarik JM; Rybak MJ; Boike SC
Clin Pharm; 1985; 4(3):311-5. PubMed ID: 4006395
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
[TBL] [Abstract][Full Text] [Related]
7. Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models.
Pryka RD; Rodvold KA; Garrison M; Rotschafer JC
Ther Drug Monit; 1989; 11(4):450-4. PubMed ID: 2741194
[TBL] [Abstract][Full Text] [Related]
8. Computer dosing program for the initiation of vancomycin therapy.
Ito MK; Duren LL; Simonian JS; Dreyfus-Vigil SD; Cookson TL
Clin Pharm; 1993 Feb; 12(2):126-30. PubMed ID: 8453861
[TBL] [Abstract][Full Text] [Related]
9. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
10. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function.
Tanaka A; Suemaru K; Otsuka T; Ido K; Nishimiya T; Sakai I; Hasegawa H; Inoue T; Murase M; Yasukawa M; Araki H
Ther Drug Monit; 2007 Apr; 29(2):261-4. PubMed ID: 17417082
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
[TBL] [Abstract][Full Text] [Related]
12. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum sampling methods for determining vancomycin dosage regimens.
Albrecht LM; Rybak MJ; Boike SC; Pancorbo S
Ther Drug Monit; 1988; 10(1):85-90. PubMed ID: 3376187
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma.
Niioka T; Uno T; Yasui-Furukori N; Takahata T; Shimizu M; Sugawara K; Tateishi T
Cancer Chemother Pharmacol; 2007 Apr; 59(5):575-80. PubMed ID: 16912889
[TBL] [Abstract][Full Text] [Related]
15. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
Rodvold KA; Blum RA
J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
[TBL] [Abstract][Full Text] [Related]
16. Individualized adjustment of vancomycin dosage: comparison with two dosage nomograms.
Rybak MJ; Boike SC
Drug Intell Clin Pharm; 1986 Jan; 20(1):64-8. PubMed ID: 3943460
[TBL] [Abstract][Full Text] [Related]
17. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
McClellan SD; Farringer JA
Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
[TBL] [Abstract][Full Text] [Related]
18. Individualizing vancomycin dosing regimens: an evaluation of two pharmacokinetic dosing programs in critically ill patients.
Fernández de Gatta MM; Fruns I; Domínguez-Gil A
Pharmacotherapy; 1994; 14(2):196-201. PubMed ID: 8197039
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait.
Al-Lanqawi Y; Capps P; Abdel-hamid M; Abulmalek K; Phillips D; Matar K; Sharma P; Thusu A
Med Princ Pract; 2007; 16(5):348-54. PubMed ID: 17709922
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin pharmacokinetics in middle-aged and elderly men.
Leonard AE; Boro MS
Am J Hosp Pharm; 1994 Mar; 51(6):798-800. PubMed ID: 8010319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
